[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![REDBOXINDIA Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1092883822473924608.png) RedboxGlobal India [@REDBOXINDIA](/creator/twitter/REDBOXINDIA) on x 367.3K followers
Created: 2025-01-24 12:59:39 UTC

TORRENT PHARMACEUTICALS: Q3 CONS NET PROFIT 5.03B RUPEES VS 4.4B (YOY) 

Q3 REVENUE 28.09B RUPEES VS 27.3B (YOY)

Q3 EBITDA 9.14B RUPEES VS 8.7B (YOY) 

Q3 EBITDA MARGIN XXXXX% VS XXXXX% (YOY)

CO DECLARED INTERIM DIVIDEND RS XX PER SHARE


XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1882775272296272214/c:line.svg)

**Related Topics**
[rs](/topic/rs)
[dividend](/topic/dividend)
[$torntpharmns](/topic/$torntpharmns)
[india](/topic/india)

[Post Link](https://x.com/REDBOXINDIA/status/1882775272296272214)